Perhaps I'll add a perspective from Genome Canada. We're not on the vaccine development side, but the network we're leading is going to be developing and generating an immense amount of data around both the virus and the number of the patients.
Everybody who is involved, from public health labs all the way through to individual researchers, is signing on to commitments to make that data publicly available and deposit that both into national efforts and also international databases that then can support worldwide efforts. It's really very much about open science in terms of the data.